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Abstract 
Two 1p36 contiguous gene deletion syndromes are known so far: the terminal 1p36 deletion 
syndrome, and a 1p36 deletion syndrome with a critical region located more proximal at 1p36.23-
1p36.22. We present even more proximally located overlapping deletions from seven individuals, 
with the smallest region of overlap comprising 1 Mb at 1p36.13-1p36.12 (chr1:19077793-20081292 
(GRCh37/hg19)) defining a new contiguous gene deletion syndrome. The characteristic features of 
this new syndrome are learning disability or mild intellectual disability, speech delay, behavioral 
abnormalities, and ptosis. The genes UBR4 and CAPZB are considered the most likely candidate 
genes for the features of this new syndrome. 
 
Keywords 




1p36 terminal deletion is considered the most common terminal deletion in humans with an incidence 
of 1 in 5000 newborns.1-3 Partial monosomy of chromosome 1p36 was first described in 1980, and in 
1997 Shapira et al. delineated the 1p36 deletion syndrome.4 The phenotype is variable with the most 
common features being intellectual disability, hypotonia, craniofacial dysmorphic features, growth 
delay, eye/vision problems, seizures and hearing impairment.4 Wu et al (1999) found the critical 
region to be of 6.29 Mb at 1p36.33-1p36.31 (chr1:1-6289973).5 In 2007 Kang et al defined a more 
proximal distinct 1p36 deletion syndrome with a critical region of 2.24 Mb at 1p36.23-1p36.22 
(chr1:9124551-11362893) in five patients.6 The features linked to this region were cognitive deficits, 
congenital malformations, hirsutism, frontal and parietal bossing, epicanthic folds, and broad and 
arched eyebrows.6 We present seven individuals from five families with even more proximally 
located overlapping interstitial deletions in 1p36.13-1p36.12 and define this as a third contiguous 




Material and methods 
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Cases with overlapping deletions in 1p36 were identified via the DECIPHER Database (Database of 
Chromosomal Imbalance and Phenotype in Humans using Ensembl Resources).7 Only individuals 
with isolated deletions less than 5 Mb were included in the study. The literature was reviewed to 
identify individuals with isolated overlapping 1p36 deletions.  
Consent for publication of clinical features and photos were obtained from all individuals shown in 
figure 1.  
Candidate genes in the smallest region of overlap (SRO) were selected as OMIM genes with a pLI 
score > 0.8 (pLI = probability of LoF intolerance) in the Genome Aggregation database (GnomAD, 
accession date July 2nd, 2019).8  
 
Results 
Clinical features are listed in Table 1, and a summary of clinical features can be seen in Table 2. 
Detailed case descriptions can be seen in supplementary material.  
Photos and schematic presentation of the 1p36 deletions are shown in Figure 1.  
The SRO for individuals presenting with learning disability or mild intellectual disability, behavioral 
anomalies, and ptosis encompassed 1 Mb at chr1:19077793-20081292 (GRCh37/hg19). Individual 8 
was described as non-dysmorphic and had a limited overlap with the SRO of 66 bp. She was not 
considered having the new microdeletion syndrome and her presence might indicate that the SRO 
could be even smaller.  
The father of individual 3 was not available for analysis, and the mother did not have the deletion. 
The array data of individual 3 revealed 35 SNPs in the region of the deletion. Nine of 35 SNPs were 
not maternally inherited, and the deletion was concluded to be of the maternal allele. The remaining 
SNPs were non-informative but in concordance with loss of maternal allele. As the mother did not 
have the deletion, we conclude, that the deletion arose de novo in individual 3. The inheritance was 
thus known in all seven individuals.  
 
Discussion 
We present seven individuals with overlapping deletions in 1p36.13-1p36.12 and define a new 
microdeletion syndrome in 1p36 located more proximal to those previously described.  
Four individuals were females, three were males. Five deletions occurred de novo (71%) while two 
siblings had inherited the deletion from their mother (29%). The majority was born at term and had a 
birth weight in the lower normal range. Postnatal growth was normal for all except one. Learning 
disability or mild intellectual disability was present in all except one who had moderate intellectual 
disability. Motor problems, behavioral anomalies and speech delay were seen in most individuals. 
Behavioral anomalies were seen in 57% (4/7), two of whom were diagnosed with ADHD. 
Dysmorphic features seen in at least 50% were congenital ptosis, pointed chin, high palate, 
misalignment of teeth, and epicanthus. Ophthalmologic features were seen in all (7/7), of which 
congenital ptosis – unilateral or bilateral – was the most distinct finding seen in 5/7 individuals (71%). 
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Less frequent were hypermetropia, epicanthus, deep-set eyes, and heavy eyebrows. Mild hearing loss 
was seen in one individual. Present in 50% or less were congenital heart defect (ASD and/or VSD, 
pulmonary valve dysplasia), and features of hands and feet such as clinodactyly, syndactyly, 
camptodactyly, and arachnodactyly.  
Congenital ptosis is a distinct feature seen in more than half of the individuals. Ptosis is defined as 
the upper eyelid being positioned lower than normal, thereby narrowing the palpebral fissures vertical 
axis. Ptosis is considered congenital, when present before one year of age. Congenital ptosis can result 
in abnormal visual function and development, such as amblyopia. The levator palpebra superior 
muscle which elevates the upper eyelid is innervated by the 3rd cranial nerve, n. oculomotorius. The 
pathophysiologic process leading to ptosis can be either neurogenic, myogenic, aponeurotic or 
mechanical9. Congenital ptosis can occur isolated or as part of a syndrome.  Congenital isolated ptosis 
most often occurs sporadically but can also be familial, and several loci and candidate genes have 
been suggested, including 1p32-1p34.110, Xq24–27.111, and the ZFH4 gene at 8q21.12.9 Congenital 
ptosis can be part of numerous genetic syndromes12, some examples are congenital fibrosis of the 
extraocular muscles (KIF21A, PHOX2A, TUBB3)13, SIX2 haploinsufficiency14, various types of 
myopathy15, neurogenetic diseases16, and mitochondrial diseases.17 The 1p36.13-1p36.12 
microdeletion syndrome presented here is a new syndrome with ptosis as a distinct feature. 
Haploinsufficiency of one or more genes in this region is suspected to cause ptosis, but the relevant 
gene/genes and pathophysiological process are unknown. 
The smallest region of overlap (SRO) encompasses 1 Mb at chr1:19077793-20081292. The SRO 
contains several genes, none of which are currently known to be haploinsufficient. The following 
genes, being the only ones with a pLI-score above 0.8, are suggested as possible candidate genes for 
features of this new microdeletion syndrome:  
The UBR4 gene (OMIM 609890), encodes a mammalian N-recognin.18 The protein is present in all 
tissues but highly expressed in nervous tissue, where it is involved in neurogenesis and neuronal 
migration, and seems to have pro-survival roles in neurons.18 UBR4 deficient mice die during 
midgestation with multiple developmental anomalies.19 In humans UBR4 has been suggested to be a 
modifier for episodic ataxia20, and has been suggested as a candidate gene for the following 
phenotypes: autism21, autosomal recessive severe intellectual disability, epilepsy, and dysarthria22.  
More studies are needed to clarify the functions of UBR4 in the brain and its role in human 
neurological diseases. While the ubiquitin ligase N-recognins are reported to be important for cardiac 
development23, UBR4 has so far not been shown to have a similar role. UBR4 is highly intolerant to 
loss of function variants with a pLI of 1.00 (GnomAD accession date October 18th, 2019). UBR4 is 
a strong candidate gene for the cognitive and behavioral symptoms in the proximal 1p36 deletion 
described here and might also be linked to ptosis and heart defects.  
The CAPZB gene (OMIM 601572) encodes the beta subunit of the CAPZ protein, an actin-capping 
protein involved in modulating actin filaments and cytoskeleton in sarcomeres in muscle. It has been 
shown to be important in embryogenesis, and regulates tissue morphogenesis and cell behavior.24 
Clinical consequences of changes in this gene is largely unknown, however, a female infant with 
congenital cleft palate, micrognathia, muscular hypotonia, and developmental delay had a de novo 
reciprocal translocation t(1;13)(p36.13;q12.1) with the breakpoint on chromosome 1 located in the 
CAPZB-gene.24 Studies on capzb-/- zebrafish support the involvement of the capzb-gene in clefting 
and micrognathia. Malformations of craniofacial skeletal muscles were seen in capzb-/- zebrafish, 
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while adult heterozygotes had subtle or no changes24. While CAPZ plays a role in cardiac 
myofilament activation23, no association to congenital heart malformation seems to exists with the 
current knowledge. CAPZB can be predicted to be LoF sensitive as the pLI is 0.91 (GnomAD 
accession date October 18th, 2019). CAPZB is also a candidate gene for at least some of the features 
of the 1p36 deletion.  
In conclusion we present a new microdeletion syndrome at proximal 1p36 (1p36.13-1p36.12) 
characterized by learning disability or mild intellectual disability, speech delay, behavioral anomalies, 
and congenital ptosis. The smallest region of overlap is extended 1 Mb spanning from 19077793 bp 
to 20081292 bp (GRCh37; hg19). We consider the genes UBR4 and CAPZB to be the best candidate 
genes for the common features. More studies are needed to describe the new deletion syndrome better 
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Figure Legends 
Figure 1: Top: Photos of the reported individuals. Numbers refer to the numbers of the individuals 
in the study. Ages at the photos are: 1) 8 years, 2) 6 years, 3) 30 years, 4) 11 years, 5) 6 months, and 
6) 16 years. The most consistent dysmorphic feature was ptosis or blepharophimosis as seen in 
individuals 1-5. Ptosis was mild in individual 2, while individuals 3, 4 and 5 had surgery for ptosis. 
Individuals 1-5 had pointed chin or “stuck-on chin”, while individual 6 had retrognathia. Bottom: 
1p36 with the positions of the terminal deletion 1p36 and the proximal deletion 1p36 as described by 
Kang et al. indicated in hatched red. To the right deletions of the reported individuals of this paper 
and those with overlapping deletions identified from literature are shown in red, as is the smallest 
region of overlap (SRO). Please note that individual 8 only had a small overlap with the SRO (66 bp), 
this individual is not considered to have the 1p36 deletion syndrome defined here. Genes included in 
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the SRO at chr1:19077793-20081292 (GRCh37/hg19) are shown with the two most likely candidate 
genes UBR4 and CAPZB (not all isoforms) encircled. 
Table I 
 Individual 1  Individual 2 Individual 3 Individual 4 Individual 5 Individual 6 Individual 7 Individual 8 
Not affected 
(Kang et al., 




Decipher ID 341356 (341356) (341356) 353614 323214 273541 353745 282936   
Sex F M F M F M M F M F 
Age at reporting 8 y 6 y 31 y 10 y 2 y 16 y 20 y 11 y - - 






















Size of deletion 1.5 Mb 1.5 Mb 1.5 Mb 2.2 Mb 2.9 Mb 3.5 Mb 4.9 Mb 619 kb 12.7 Mb 7.8 Mb 
Inheritance MI MI Dn Dn Dn Dn Dn ?, not MI - - 
Cognition LD (IQ 80) LD (IQ 80) LD LD - Moderate ID Mild ID LD - Cognitive 
impairment 













disorder at 19y 
ADHD  Normal  Tantrums and 
night terrors as 
young child 











fine and gross 
motor skills as 
a child 




Age at walking 16 m 16 m 13 m - 21 m 24 m - - - - 
Congenital heart 
defects 
Small ASD and 
VSD (resolved 
spontaneously) 
No No Small 
secundum 
ASD 
No No Subaortic 
VSD 
(surgery 9m) 






Hypermetropia  Hypermetropia - No Convergent 
squint. Partial 




No - - - 
Skeletal features - - - - - - Scoliosis - - Kyphosis 
Other features Tubulated 1y, 
tonsillectomia 
and polypec-
tomia at 2y 
Periods with 
















Table I continued 
 Individual 1  Individual 2 Individual 3 Individual 4 Individual 5 Individual 6 Individual 7 Individual 8 
Not affected 
(Kang et al., 
2007), case 1  
(Zaveri et 
al., 2014), 
case 7  
Congenital ptosis Yes Yes (mild) Yes Yes Yes No No No Yes - 
Eye, other Heavy eyebrows Upslant pf Heavy 
eyebrows 








- S-shaped pf  
High plate Yes - - No Yes Yes Yes - - - 
Teeth Misaligned Overbite - - - Misaligned Misaligned - - - 
Pointed chin Yes Yes Yes Yes Yes Yes Yes - - - 
Hands and feet - Clinodactyly of 
right hand 2. 
and 5. finger 
and left 5. 
finger, simian 












of the digits 
Camptodactyl
y of 3rd, 4th 
and 5th digits 
bilateral  
- 






















        
Intellectual disability or learning disability 5/7               
Speech delay 5/6               
Motor delay 5/5               
Behavioral anomalies 4/7               
Congenital heart malformation 3/7               
Congenital ptosis 5/7               
Pointed or “stuck on” chin 6/7               
High palate 4/5               




Figure 1: Top: Photos of the reported individuals. Numbers refer to the numbers of the individuals 
in the study. Ages at the photos are: 1) 8 years, 2) 6 years, 3) 30 years, 4) 11 years, 5) 6 months, 
and 6) 16 years. The most consistent dysmorphic feature was ptosis or blepharophimosis as seen 
in individuals 1-5. Ptosis was mild in individual 2, while individuals 3, 4 and 5 had surgery for 
ptosis. Individuals 1-5 had pointed chin or “stuck-on chin”, while individual 6 had retrognathia. 
Bottom: 1p36 with the positions of the terminal deletion 1p36 and the proximal deletion 1p36 as 
described by Kang et al. indicated in hatched red. To the right deletions of the reported individuals 
of this paper and those with overlapping deletions identified from literature are shown in red, as is 
the smallest region of overlap (SRO). Please note that individual 8 only had a small overlap with 
the SRO (66 bp), this individual is not considered to have the 1p36 deletion syndrome defined here. 
Genes included in the SRO at chr1:19077793-20081292 (GRCh37/hg19) are shown with the two 
most likely candidate genes UBR4 and CAPZB (not all isoforms) encircled. 
Appendix: Clinical information 
 
Individual 1 (Decipher ID 341356) is the older maternal half-sister of individual 2. Due to IUGR 
the pregnancy was followed with ultrasound scans and the birth was induced but progressed 
vaginally uncomplicated. She was born at gestational age 39+6 with Apgar scores 9/1, 10/5. The 
birth weight was 2676 g (-2 SD), length 48 cm (-1 SD), and head circumference 34 cm (slightly 
below median). She had bilateral ptosis, most pronounced on the right eye. She cried a lot the first 
half year, feeding was normal. Early motor development was normal, and she walked at age 16 
months. She had one febrile seizure at age 1 year. She was tubulated at 1 year and 3 months of age 
and had tonsillectomy and polypectomy at 2 years of age. Echocardiography soon after birth 
showed discrete ASD and VSD, which had resolved spontaneously at age 1 year. She had speech 
delay and a challenging behavior with hyperactivity, concentration difficulties, and reduced self-
control. At 5 years and 4 months of age she was seen at the children psychiatric department under 
suspicion of ADHD, but she was too young to get this diagnosis. She attended normal elementary 
school but has learning difficulties. She had difficulties in motor skills with balancing and 
bicycling. At age 8 years and 8 months height was 127 cm (-1 SD), weight 24 kg (-1 SD), and head 
circumference 51 cm (-1 SD). Dysmorphic features were bilateral ptosis, thick eyebrows, 
misalignment of teeth, high palate, and protruding chin. Hands and feet were normal. A WISC-IV 
test at 8 year of age showed a total IQ of 80 with results of subtests spanning from 93 in verbal 
understanding to 69 in working memory.  
 
Individual 2 (related to Decipher ID 341356) is the younger maternal half-brother of individual 1. 
He was born by uncomplicated vaginal delivery at gestational week 39+6 with Apgar scores 9/1, 
10/5, and birth weight of 3610 grams (median), length 52 cm (median) and head circumference 36 
cm (+1SD). At age 6 weeks he was admitted to the hospital after several apneic episodes at home.  
He walked at 16 months of age. He had speech delay and received speech therapy, and he had a 
tendency of falling. He had sleeping difficulties and uses a chain-quilt. He was described as 
hyperactive and easily distractible, and playing with other children requires adult supervision. He 
had hypermetropy +3 bilaterally. At age 6½ years height was 120 cm (- 0,5 SD), weight 22,9 kg 
(median), and head circumference 51 cm (median). He had elongated face, triangular protruding 
chin, slight bilateral ptosis and bilateral epicanthus, upwards slanting palpebral fissures and a slight 
overbite. Clinodactyly of 2. and 5. finger on the right hand and the 5. finger on the left hand as well 
as a simian crease on the left hand was seen. A WPPSI-IV test at 6 age years showed a total IQ of 
80 with subtest results spanning from 103 in visuo-spatial understanding to 72 in verbal 
understanding.  
 
Individual 3 (related to Decipher ID 341356) is the mother of individual 1 and 2. She was born at 
gestational week 39+2 with birthweight 3000 grams. She had congenital ptosis on the right eye and 
underwent surgery for this at 11 years of age. She had pes planus. She was diagnosed with mild 
developmental disorder of the type Minimal Brain Dysfunction as a young child, and later with 
attention deficit. She had difficulties in both fine and gross motor skills. In adulthood she was 
suspected for emotional personality disorder, but later she was diagnosed with ADHD for which she 
receives medical treatment (methylphenidat). At age 31 she was seen with heavy eyebrows, almond 
shaped eyes, angulated rim of upper eyelid on the right eye (after surgery for ptosis), broad nose, 
plump upper lip, and protruding chin. Hands and feet were normal. 
 
Individual 4 (Not consented in Decipher) is a 10 year old boy with a small secundum ASD, but 
normal growth. Head circumference at 10 years and 10 months of age was 54.5cm (75th centile). 
He has behavioral problems and is diagnosed with ADHD for which he receives medical treatment 
(methylphenidate). Speech and language development was delayed. No words were used until 5 
years of age. He receives speech therapy. Motor and social development were not delayed. He has 
learning difficulties. He had significant congenital bilateral ptosis for which he had surgery. 
Dysmorphic characteristics are  small ear canals and small nipples. His speech is nasal (at 6 years of 
age he had adenotonsillectomy). 
 
Individual 5 (Decipher ID 323214) is the first child born to healthy non-consanguineous white, 
European parents. Mother remained well during pregnancy, and patient was born at 39+2/40 
gestation. Birth weight was 2920 grams and she did note require resuscitation or special care. 
Congenital ptosis was present, for which the patient underwent repair at 6 months of age. Her 
developmental impairment is predominantly motor: She sat at 8 months and has been cruising since 
21 months. She had multiple words and was able to construct two-word phrases at 2 years of age. 
Her dysmorphic features include: Slender eyes, high forehead, high arched palate and pointed chin. 
Her general health is good. Her medical history includes eczema, convergent squint, partial 3rd and 
6th nerve palsy, large angle esotropia. There is nil significant in the family history aside from both 
parents having dyslexia. Investigations to date: Biochemical profile normal. MRI brain and orbits 
aged 1 year was normal. KAT6B testing negative. Patient has been recruited into 100,000 genomes 
project. She continues to have regular physiotherapy input and is also under the care of the 
ophthalmology and general pediatric teams. 
 
Individual 6 (Decipher ID 273541) is the male only child of non-consanguineous white British 
parents. The patient was referred to the Genetics Clinic at 3 years of age with concerns about his 
poor growth and speech delay. There was a history of short stature in his father (154cm, 
<0.4th centile) but he had a normal OFC (54 cm, 2nd centile) and no intellectual disability. The 
patient’s mother was of normal height (161.5cm, 25th centile), OFC (56.1 cm, 75th centile) and 
intellect. There was no other family history of note. The patient was born by ventouse delivery at 38 
weeks gestation following an uncomplicated pregnancy. His birth weight was 2500g (2nd-9th centile) 
and birth OFC 33.5cm (25th-50th centile). APGARS were 4 at 1 minute and 8 at 5 minutes. He 
required some bag and mask resuscitation and fed poorly in the first 24 hours but was discharged 
home at 48 hours of age. The patient bottle fed reasonably in infancy but only small volumes which 
were taken slowly. His weight fell below the 0.4th centile by 6 months of age and he remained small 
during childhood. The patient sat and crawled at 12 months and walked at 2 years. His OFC was 
45.5 cm at 2 years and 10 months of age (<0.4th centile). When assessed at 3 years and 5 months of 
age he was still using single words. The patient had feeding difficulties (poor appetite, reluctant to 
chew, easy vomiting, milk coming out his nose) and frequent ear infections. A tonsillectomy was 
performed at 6 years of age and his feeding subsequently improved. The patient had particular 
difficulties with pronunciation and expressive language. He received speech therapy. He had 
eczema and a mild hearing impairment. There were no concerns about his vision. His behavior was 
generally good although his communication difficulties would sometimes make him frustrated. He 
generally slept well but was often restless in bed.  
The patient was last assessed at 16 years and 3 months of age. He attended a special unit in a 
mainstream school. He was short with moderate intellectual disability and microcephaly. His speech 
and feeding were significantly improved. He had no history of seizures. He had a persistent cough 
which was thought to be due to either post-nasal drip or silent reflux, and he was having a trial of 
decongestant nasal spray, anti-reflux drugs (Gaviscon), proton pump inhibition drugs (omeprazole) 
and antihistamines. His growth parameters were height 159.2 cm (2nd centile), weight 39 kg 
(<0.4th centile) and OFC 50.5 cm (<0.4thcentile). He had a pointed chin, slightly small deep-set 
eyes, large ears, malar hypoplasia, high palate and mildly misalignment of teeth. There was bilateral 
5th finger camptodactyly and mild 2-3 toes syndactyly. His cardiovascular examination was normal. 
His neurological examination was normal apart from some mild muscular hypotonia. 
  
Karyotype (46, XY), testing for Fragile X, TORCH screen, thyroid function test, sweat test, coeliac 
screen and basic hematology/biochemistry were all normal. Immunoglobulins were normal apart 
from a slightly reduced IgM level. Hand and foot X-rays and a head CT (at 3 years of age) were all 
reported to be normal. Array CGH found a 3.4 Mb deletion at 1p36.12 (19,098,854bp to 22,517,879 
[hg19]). The deletion was confirmed by FISH and shown to be de novo by parental testing. 
 
Individual 7 (Decipher ID 353745) is a 20 years-old boy, the 4th child of healthy non-
consanguineous parents. The birth weight was 2750 g and Apgar score was 6 at 1 min and 7 at 5 
min. At birth congenital heart defects with a subaortic ventricular septal defect (VSD), surgically 
corrected at 9 months, and pulmonary valve dysplasia were diagnosed. He showed persistent 
leukopenia due to EBV infection and thrombocytopenia. During the first months of his life, a 
pneumonia episode occurred. Physical examination at 20 years of age showed height 172 cm (3rd 
centile) and weight 58.9 kg (3rd centile). Craniofacial dysmorphisms consisted of long face, deep-
set eyes, synophrys, thin palpebral fissures, blepharophimosis, short philtrum, ogival palate, 
scoliosis, arachnodactyly. His cognitive functioning was mildly impaired and scholar supporting 
was needed. 
 
Individual 8 (Decipher ID 282936) is an 11 years old girl. She struggles with reading and writing 
and telling time and is assessed for dyslexia. She is good with money. She has short attention span 
but can fix on things if interested. She is good verbally and enjoys debating at school, and she has 
good memory for information she has been told or has seen on TV. She is prone to constipation and 
soiling and is treated with Movicol. She has been seen by Child and Adolescent Mental services 
because of lack of emotions and inappropriate reactions to death/ life-threatening or embarrassing 
situations.  She is non-dysmorphic and does not have ptosis or any behaviour to suggest ADHD. 
She was said to be unable to sit still but did ok academically. It is not possible to get a sample from 
Dad. 
